SFX by Ex Libris Inc.

Title:	Functional Characterization ofttmMUnveils New Tautomycin Analogs and Insight into Tautomycin Biosynthesis and Activity
Source:	Organic Letters [1523-7060] Ju, Jianhua yr:2009

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wang, X. "Novel fatty acid synthase (FAS) inhibitors: Design, synthesis, biological evaluation, and molecular docking studies." Bioorganic & medicinal chemistry 17.5 (2009): 1898-1904.
description	2.	Barkovich, R.J. J. "Characterization of the COQ5 gene from Saccharomyces cerevisiae: Evidence for a C-methyltransferase in ubiquinone biosynthesis." The Journal of biological chemistry 272.14 (1997): 9182-9188.
description	3.	McCluskey, Timothy P. "Norcantharidin Analogues: Synthesis, Anticancer Activity and Protein Phosphatase 1 and 2A Inhibition." ChemMedChem 3.12 (2008): 1878-1892.
description	4.	Tsuboi, K. "Synthesis of okadaic acid-tautomycin hybrid." Synlett 6 (1997): 713-715.
description	5.	Knirschova, R. "Multiple regulatory genes in the salinomycin blosynthetic gene cluster of streptomyces albus CCM 4719." Folia microbiologica 52.4 (2007): 359-365.
description	6.	Ogretmen, B. "Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling." The FASEB journal 23.3 (2009): 751-63.
description	7.	Schafer, H. "Discovery of (S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl] acetamide (apremilast), a potent and orally active phosphodiesterase 4 and tumor necrosis factor-alpha inhibitor." Journal of medicinal chemistry 52.6 (2009): 1522-4.
description	8.	Maier, T. "The Crystal Structure of a Mammalian Fatty Acid Synthase." Science 321.5894: 1315-22.
description	9.	Ruderman NB, Edward B. "Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity." Endocrinology 144.12 (2003): 5166-71.
description	10.	Seki, M. "A novel synthesis of a key intermediate for (+)-biotin from L-aspartic acid." Synthesis 3 (2002): 361-364.
description	11.	Bililign, T. "The Hedamycin Locus Implicates a Novel Aromatic PKS Priming Mechanism." Chemistry & biology 11.7 (2004): 959-69.
description	12.	Okauchi, T. "2-Phosphono-1,1,4,4-tetrathio-1,3-butadienes. Synthesis and synthetic application to highly functionalized dienes and heterocycles." Bulletin des sociétés chimiques belges 106.9 (1997): 525-.
description	13.	Muraoka, O. "Synthesis and biological evaluation of deoxy salacinols, the role of polar substituents in the side chain on the Î±-glucosidase inhibitory activity." Bioorganic & medicinal chemistry 14.2 (2006): 500-6515.
description	14.	Jenni, S. "Structure of Fungal Fatty Acid Synthase and Implications for Iterative Substrate Shuttling." Science 316.5822 (2007): 254-61.
description	15.	McDonald, Iain M. "Discovery and Characterization of Novel, Potent, Non-Peptide Parathyroid Hormone-1 Receptor Antagonists." Journal of medicinal chemistry 50.20 (2007): 4789-4792.
description	16.	Kimball, Scot R. R. "Regulation of protein synthesis associated with skeletal muscle hypertrophy by insulin-, amino acid- and exercise-induced signalling." Proceedings of the Nutrition Society 63.2 (2004): 351-6.
description	17.	Briand, Cynthia A. "A human fatty acid synthase inhibitor binds β-ketoacyl reductase in the keto-substrate site." Nature Chemical Biology 10.9 (2014): 774-9.
description	18.	Abel, Jean L. "Running-induced epigenetic and gene expression changes in the adolescent brain." International journal of developmental neuroscience 31.6 (2013): 382-390.
description	19.	Engel, R. "Phosphorus Addition atsp2Carbon." 2004.
description	20.	Pacofsky, G. "Relating the Structure, Activity, and Physical Properties of Ultrashort-Acting Benzodiazepine Receptor Agonists." Bioorganic and medicinal chemistry letters 12.21 (2002): 3219-3222.